Evidence map›Paper›PMID 39881142›Full record

ArticleScientific reports2025

A deep learning analysis for dual healthcare system users and risk of opioid use disorder.

Ying Yin, Elizabeth Workman, Phillip Ma, Yan Cheng, Yijun Shao, Joseph L Goulet, Friedhelm Sandbrink, Cynthia Brandt, Christopher Spevak, Jacob T Kean and 8 more

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Ying YinWashington DC VA Medical Center, Washington, DC, USA.
Elizabeth WorkmanWashington DC VA Medical Center, Washington, DC, USA.
Phillip MaWashington DC VA Medical Center, Washington, DC, USA.
Yan ChengWashington DC VA Medical Center, Washington, DC, USA.
Yijun ShaoWashington DC VA Medical Center, Washington, DC, USA.
Joseph L GouletVA Connecticut Healthcare System, West Haven, CT, USA.
Friedhelm SandbrinkWashington DC VA Medical Center, Washington, DC, USA.
Cynthia BrandtVA Connecticut Healthcare System, West Haven, CT, USA.
Christopher SpevakGeorgetown University School of Medicine, Washington, DC, USA.
Jacob T KeanThe University of Utah, Salt Lake City, UT, USA.
William BeckerVA Connecticut Healthcare System, West Haven, CT, USA.
Alexander LibinGeorgetown University School of Medicine, Washington, DC, USA.
Nawar SharaGeorgetown University School of Medicine, Washington, DC, USA.
Helen M SheriffWashington DC VA Medical Center, Washington, DC, USA.
Jorie ButlerThe University of Utah, Salt Lake City, UT, USA.
Rajeev M AgrawalMedStar Health, Washington, DC, USA.
Joel Kupersmith *Georgetown University School of Medicine, Washington, DC, USA. jk1688@georgetown.edu.
Qing Zeng-Trietler *Washington DC VA Medical Center, Washington, DC, USA. zengq@gwu.edu.

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
HSRD VA I01 HX003100NCATS NIH HHS UL1 TR001863United States Department of Veterans Affairs 1I01HX003100-01A2
6 · The paper itself

Abstract

The opioid crisis has disproportionately affected U.S. veterans, leading the Veterans Health Administration to implement opioid prescribing guidelines. Veterans who receive care from both VA and non-VA providers-known as dual-system users-have an increased risk of Opioid Use Disorder (OUD). The interaction between dual-system use and demographic and clinical factors, however, has not been previously explored. We conducted a retrospective study of 856,299 patient instances from the Washington DC and Baltimore VA Medical Centers (2012-2019), using a deep neural network (DNN) and explainable Artificial Intelligence to examine the impact of dual-system use on OUD and how demographic and clinical factors interact with it. Of the cohort, 146,688(17%) had OUD, determined through Natural Language Processing of clinical notes and ICD-9/10 diagnoses. The DNN model, with a 78% area under the curve, confirmed that dual-system use is a risk factor for OUD, along with prior opioid use or other substance use. Interestingly, a history of other drug use interacted negatively with dual-system use regarding OUD risk. In contrast, older age was associated with a lower risk of OUD but interacted positively with dual-system use. These findings suggest that within the dual-system users, patients with certain risk profiles warrant special attention.

Indexed as

Deep LearningOpioid-Related DisordersAdultAnalgesics, OpioidFemaleHumansMaleMiddle AgedRetrospective StudiesRisk FactorsUnited StatesUnited States Department of Veterans AffairsVeteransAnalgesics, OpioidDeep neural networkDual-system useExplainable AIInteractionOpioid use disorder

Identifiers

PMID39881142
PMCPMC11779826

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.